CSA Research report on ModelFront for a clinical research organization
28 April 2026
CSA Research has published a new report on how a CRO uses ModelFront to automate millions of words of translation of highly regulated clinical trial content.
- Approximately 60 million new words checked by AI annually
- Integrated into on-premise workflows with multiple human steps
- Fully auditable and compliant with HIPAA and GDPR
ModelFront Brings Quality Estimation to Regulated Clinical Content at Scale
Alison Toon, 28 April 2026Enterprises in regulated industries face pressure to scale localization while maintaining strict quality, compliance, and risk controls, raising questions about how far artificial intelligence can safely reduce – or help – human effort.
This briefing shows how ModelFront applies automated quality estimation to minimize the first post-editing stage, targeting the highest-cost step while maintaining the stringent required quality thresholds and auditability.
The results indicate a shift toward confidence-driven workflows where artificial intelligence directs human effort rather than replaces it, especially in high-risk environments.
This matters because it enables cost and time reduction without compromising regulatory requirements. Enterprise buyers in all industries can use this report to evaluate AI adoption strategies and optimize localization workflows.
CSA Research is a leading independent industry research firm focused on the translation industry, trusted by enterprise translation and localization teams for two decades.
Read the full report on CSA Research → (opens in a new tab)